Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

Impact of rotavirus vaccine on paediatric rotavirus hospitalisation and intussusception in New Zealand: A retrospective cohort study.

McIlhone KA, Best EJ, Petousis-Harris H, Howe AS.

Vaccine. 2020 Feb 11;38(7):1730-1739. doi: 10.1016/j.vaccine.2019.12.045. Epub 2019 Dec 27.

PMID:
31889608
2.

A Retrospective Cohort Study of Safety Outcomes in New Zealand Infants Exposed to Tdap Vaccine in Utero.

Petousis-Harris H, Jiang Y, Yu L, Watson D, Walls T, Turner N, Howe AS, Griffin JB.

Vaccines (Basel). 2019 Oct 11;7(4). pii: E147. doi: 10.3390/vaccines7040147.

3.

Pertussis Vaccination Failure in the New Zealand Pediatric Population: Study Protocol.

Chisholm H, Howe A, Best E, Petousis-Harris H.

Vaccines (Basel). 2019 Jul 16;7(3). pii: E65. doi: 10.3390/vaccines7030065.

4.

Exploitation of Neisseria meningitidis Group B OMV Vaccines Against N. gonorrhoeae to Inform the Development and Deployment of Effective Gonorrhea Vaccines.

Petousis-Harris H, Radcliff FJ.

Front Immunol. 2019 Apr 9;10:683. doi: 10.3389/fimmu.2019.00683. eCollection 2019. Review.

5.
6.

Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort Study.

Paynter J, Goodyear-Smith F, Morgan J, Saxton P, Black S, Petousis-Harris H.

Vaccines (Basel). 2019 Jan 5;7(1). pii: E5. doi: 10.3390/vaccines7010005.

7.

Comparison of vaccination coverage of four childhood vaccines in New Zealand and New York State.

Baumann KE, Paynter J, Petousis-Harris H, Prymula R, Yang YT, Shaw J.

J Paediatr Child Health. 2019 Jul;55(7):781-788. doi: 10.1111/jpc.14289. Epub 2018 Nov 13.

PMID:
30426581
8.

Pneumococcal Conjugate Vaccines Turning the Tide on Inequity: A Retrospective Cohort Study of New Zealand Children Born 2006-2015.

Petousis-Harris H, Howe AS, Paynter J, Turner N, Griffin J.

Clin Infect Dis. 2019 Feb 15;68(5):818-826. doi: 10.1093/cid/ciy570.

PMID:
30032236
9.

Pertussis Immunisation in Pregnancy Safety (PIPS) Study: A retrospective cohort study of safety outcomes in pregnant women vaccinated with Tdap vaccine.

Griffin JB, Yu L, Watson D, Turner N, Walls T, Howe AS, Jiang Y, Petousis-Harris H.

Vaccine. 2018 Aug 16;36(34):5173-5179. doi: 10.1016/j.vaccine.2018.07.011. Epub 2018 Jul 18.

PMID:
30031662
10.

Author reply to VA-MENGOC-BC cross-protection (2018HV0022).

Petousis-Harris H.

Hum Vaccin Immunother. 2018 May 4;14(5):1069. doi: 10.1080/21645515.2018.1448335. Epub 2018 Apr 30. No abstract available.

11.

Pitfalls of the healthy vaccinee effect - Authors' reply.

Petousis-Harris H, Paynter J, Morgan J, Saxton P, Goodyear-Smith F, Black S.

Lancet. 2018 Jan 13;391(10116):123-124. doi: 10.1016/S0140-6736(18)30018-7. No abstract available.

PMID:
29353622
12.

Impact of meningococcal group B OMV vaccines, beyond their brief.

Petousis-Harris H.

Hum Vaccin Immunother. 2018 May 4;14(5):1058-1063. doi: 10.1080/21645515.2017.1381810. Epub 2017 Nov 17.

13.

Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study.

Petousis-Harris H, Paynter J, Morgan J, Saxton P, McArdle B, Goodyear-Smith F, Black S.

Lancet. 2017 Sep 30;390(10102):1603-1610. doi: 10.1016/S0140-6736(17)31449-6. Epub 2017 Jul 10.

PMID:
28705462
14.

Age-specific effectiveness following each dose of acellular pertussis vaccine among infants and children in New Zealand.

Radke S, Petousis-Harris H, Watson D, Gentles D, Turner N.

Vaccine. 2017 Jan 3;35(1):177-183. doi: 10.1016/j.vaccine.2016.11.004. Epub 2016 Nov 18.

15.

Safety of Tdap vaccine in pregnant women: an observational study.

Petousis-Harris H, Walls T, Watson D, Paynter J, Graham P, Turner N.

BMJ Open. 2016 Apr 18;6(4):e010911. doi: 10.1136/bmjopen-2015-010911.

16.

Infant outcomes after exposure to Tdap vaccine in pregnancy: an observational study.

Walls T, Graham P, Petousis-Harris H, Hill L, Austin N.

BMJ Open. 2016 Jan 6;6(1):e009536. doi: 10.1136/bmjopen-2015-009536.

17.

Proposed HPV vaccination syndrome is unsubstantiated.

Petousis-Harris H.

Clin Rheumatol. 2016 Mar;35(3):833-4. doi: 10.1007/s10067-015-3090-z. Epub 2015 Oct 21. No abstract available.

PMID:
26490038
18.

Factors associated with reported pain on injection and reactogenicity to an OMV meningococcal B vaccine in children and adolescents.

Petousis-Harris H, Jackson C, Stewart J, Coster G, Turner N, Goodyear-Smith F, Lennon D.

Hum Vaccin Immunother. 2015;11(7):1875-80. doi: 10.1080/21645515.2015.1016670.

19.

Pneumococcal disease in New Zealand and prevailing inequalities, the tip of the lower respiratory infection iceberg.

Petousis-Harris HA.

N Z Med J. 2013 Jul 12;126(1378):9-11. No abstract available.

PMID:
24045310
20.

An investigation of three injections techniques in reducing local injection pain with a human papillomavirus vaccine: a randomized trial.

Petousis-Harris H, Poole T, Stewart J, Turner N, Goodyear-Smith F, Coster G, Lennon D.

Vaccine. 2013 Feb 6;31(8):1157-62. doi: 10.1016/j.vaccine.2012.12.064. Epub 2013 Jan 8.

PMID:
23306361

Supplemental Content

Loading ...
Support Center